CDC Advisers Recommend Pfizer COVID-19 Booster Shot for Older, At-Risk Americans

Vaccine advisers to the United States Centers for Disease Control and Prevention (CDC) recommended giving the Pfizer COVID-19 booster shot to certain at-risk groups of people.

Members of the Advisory Committee on Immunization Practices voted on Sept. 23 to recommend the booster shot to people aged 65 and above, those in long-term care facilities, and people aged 50 to 64 years old with underlying medical conditions.

The recommendation came short of the Food and Drug Administration’s emergency use authorization on Sept. 22, which gave full endorsement for other groups of at-risk people, including allowing people aged 18 to 49 with underlying medical conditions, the booster shot to people aged 18 and people aged 18 to 64 at high risk of COVID-19 exposure at work, such as healthcare workers and teachers.

The advisers stressed that the recommendations will be updated as more data come in.

The booster shot would be administered at least six months after the primary two-dose vaccination series.

The vote will now go to CDC Director Dr. Rochelle Walensky for the final sign off.


© Fourth Estate® — All Rights Reserved.
This material may not be published, broadcast, rewritten or redistributed.